Givaudan SA (OTCMKTS:GVDNY - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 6,000 shares, a growth of 1,900.0% from the March 31st total of 300 shares. Based on an average trading volume of 62,200 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.
Analysts Set New Price Targets
Separately, Berenberg Bank raised Givaudan from a "hold" rating to a "strong-buy" rating in a report on Friday, February 14th.
Check Out Our Latest Stock Report on GVDNY
Givaudan Trading Up 0.8 %
Shares of OTCMKTS GVDNY traded up $0.71 during trading on Friday, reaching $93.81. The company had a trading volume of 8,019 shares, compared to its average volume of 28,462. Givaudan has a 52 week low of $81.37 and a 52 week high of $110.32. The business's 50 day moving average price is $89.27 and its 200-day moving average price is $89.63. The company has a current ratio of 1.43, a quick ratio of 0.94 and a debt-to-equity ratio of 0.99.
Givaudan Increases Dividend
The business also recently disclosed a dividend, which was paid on Wednesday, April 9th. Investors of record on Tuesday, March 25th were given a $1.5503 dividend. The ex-dividend date was Tuesday, March 25th. This is a boost from Givaudan's previous dividend of $0.97.
Givaudan Company Profile
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
